# FDA 483 - Cipla, Ltd. - November 30, 2018

Source: https://www.globalkeysolutions.net/records/483/cipla-ltd/073508e0-bb26-49d8-a957-16fbe67ca9f6

> FDA 483 for Cipla, Ltd. on November 30, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cipla, Ltd.
- Inspection Date: 2018-11-30
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I

## Related Documents

- [483 - 2018-11-30](https://www.globalkeysolutions.net/records/483/cipla-ltd/c2182f72-76c8-4eda-b528-fd5f65155e44)
- [483 - 2019-03-20](https://www.globalkeysolutions.net/records/483/cipla-ltd/4f536fa1-9193-4e02-8c65-9f726b4bc1da)
- [483 - 2024-05-08](https://www.globalkeysolutions.net/records/483/cipla-ltd/49e75f7a-9d48-4aab-b5d8-fcdacd62e11c)
- [483 - 2024-05-06](https://www.globalkeysolutions.net/records/483/cipla-ltd/7c8e1395-291d-4698-ad4d-88a7bde50b11)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/rozelle-g-smith/cd2488c0-fe18-4fc4-a80e-20d08a8d12cc)

Company: https://www.globalkeysolutions.net/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1